Jens Ulrik Holst
Plus aucun poste en cours
Historique de carrière de Jens Ulrik Holst
Anciens postes connus de Jens Ulrik Holst
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Arlington Capital Investors Ltd.
 Arlington Capital Investors Ltd. Financial ConglomeratesFinance Arlington Capital Investors Ltd. (Arlington) is the investment management subsidiary of Arlington Capital Management (CI) Ltd. (Guernsey). The firm was founded in 1991 and is based in London. In addition to investing in a limited number of quoted companies around the themes of industrial reform, corporate restructuring and shareholder value, Arlington manages the European Renaissance Fund. | Membre du Comité d'Investissement | 01/09/2003 | 01/02/2010 |
| Sales & Marketing | 01/09/2003 | 01/02/2010 | |
Origio A/S
 Origio A/S BiotechnologyHealth Technology ORIGIO A/S manufactures and markets assisted reproduction technologies and related human reproductive products. Its products include Andrology, sequential series, EmbryoGem, BlastGen, Pipettes, ICSI micropipets. The company was founded in 1987 and is headquartered in Maaloev, Denmark. | Président | 31/03/2010 | 31/03/2010 |
Formation de Jens Ulrik Holst
| University of Mannheim | Masters Business Admin |
Statistiques
Internationale
| Royaume-Uni | 2 |
| Allemagne | 2 |
| Danemark | 2 |
Opérationnelle
| Investment Committee Member | 1 |
| Sales & Marketing | 1 |
| Masters Business Admin | 1 |
Sectorielle
| Finance | 2 |
| Consumer Services | 2 |
| Health Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Arlington Capital Investors Ltd.
Arlington Capital Investors Ltd. Financial ConglomeratesFinance Arlington Capital Investors Ltd. (Arlington) is the investment management subsidiary of Arlington Capital Management (CI) Ltd. (Guernsey). The firm was founded in 1991 and is based in London. In addition to investing in a limited number of quoted companies around the themes of industrial reform, corporate restructuring and shareholder value, Arlington manages the European Renaissance Fund. | Finance |
Origio A/S
Origio A/S BiotechnologyHealth Technology ORIGIO A/S manufactures and markets assisted reproduction technologies and related human reproductive products. Its products include Andrology, sequential series, EmbryoGem, BlastGen, Pipettes, ICSI micropipets. The company was founded in 1987 and is headquartered in Maaloev, Denmark. | Health Technology |
- Bourse
- Insiders
- Jens Ulrik Holst
- Expérience
